ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Focusing on Interior and Exterior: the Chinese Psoriasis Drug Market to Usher in a Great Change
October 25, 2019Eli Lilly announced on Sep. 4 that its new psoriasis drug: ixekizumab (Taltz®) had entered China and passed the marketing approval of the NMPA, which is another blockbuster psoriasis drug approved following the approval of the “first-in-class” new drug be
Pharma Sources Insight January 2025
